CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BACHEM HOLDING AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BACHEM HOLDING AG
Hauptstrasse 144
Phone: +41 619352333p:+41 619352333 BUBENDORF, 4416  Switzerland Ticker: BANBBANB
Business Summary
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board KunoSommer 68 1/1/2012 1/1/2012
Chief Executive Officer, Chief Operating Officer, Member of the Corporate Executive Committee ThomasMeier 56 1/1/2023 1/1/2019
Non-Executive Vice Chairwoman of the Board Nicole G.Hoetzer 51 1/1/2011 1/1/2011
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bachem Americas, Inc. 3132 Kashiwa Street Torrance CA United States

Business Names
Business Name
Bachem (UK) Ltd.
Bachem AG
Bachem AG
6 additional Business Names available in full report.

General Information
Number of Employees: 2,009 (As of 6/30/2024)
Outstanding Shares: 74,973,645 (As of 6/30/2024)
Shareholders: 11,954
Stock Exchange: SWF
Fax Number: +41 619352324


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 21, 2024